Roivant Sciences Ltd (ROIV)
Fixed asset turnover
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 90,017 | 87,063 | 67,973 | 44,317 | 33,312 | 22,259 | 36,493 | 44,730 | 48,245 | |||
Property, plant and equipment | US$ in thousands | 19,058 | 21,857 | 24,477 | 36,270 | 39,086 | 37,295 | 39,171 | 31,689 | 25,905 | 21,606 | 16,904 | 15,550 |
Fixed asset turnover | 4.72 | 3.98 | 2.78 | 1.22 | 0.85 | 0.60 | 0.93 | 1.41 | 1.86 |
March 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $90,017K ÷ $19,058K
= 4.72
The fixed asset turnover ratio of Roivant Sciences Ltd has demonstrated significant improvement over the past few quarters. The ratio increased steadily from 1.86 in Mar 31, 2022, to 4.72 in Mar 31, 2024. This indicates that the company is generating more revenue relative to its investment in fixed assets, reflecting improved efficiency in asset utilization.
The substantial increase in fixed asset turnover signifies that Roivant Sciences Ltd's management has been successful in optimizing the utilization of fixed assets to generate sales. This can be attributed to effective operational management, cost-efficient production processes, and possibly strategic investments in enhancing asset productivity.
Overall, the upward trend in the fixed asset turnover ratio suggests that Roivant Sciences Ltd is making efficient use of its fixed assets to drive revenue growth, which is a positive indicator of the company's operational performance and financial health.
Peer comparison
Mar 31, 2024